Bibliography
- Diabetes (1997) 46\(Suppl. 1):1A–392A.
- HOFMANN CA, COLCA JR: New oral thiazolidinedione antidiabetic agents act as insulin sensitizers.DiabeL Care (1992) 15(8):1075–1078.
- PETRIE J, SMALL M, CONNELL-J: `Glitazones', a prospect for non-insulin-dependent diabetes. Lancet (1997) 349 (9045):70–71.
- METER AH, CINCOTTA AH, LOVELL WC: Timed bro-mocriptine administration reduces body fat stores in obese subjects and hyperglycemia in Type 2 diabetics. Experientia (1992) 48(3) :248–253.
- BODEN G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes (1997) 46(1): 3–10.
- RUBIN RJ, ALLTMAN VVM, MENDELSON DM: Healthcare expenditures for people with diabetes mellitus, 1992.J. Clin. Endocrinol Metab. (1994) 78:809A–809F.
- GERICH JE: Pathogenesis and treatment of Type 2 (non-insulin-dependent) diabetes mellitus (NIDDM). Horm. Metab. Res. (1996) 28(9):404–412. Jerry Colca Endocrine Pharmacology and Metabolism, Pharmacia & Upjohn, Inc., 301 Henrietta St., Kalamazoo, MI 49007–0199, USA